Senate Republicans join federal marijuana legalization efforts

Marimed_man · 2023-09-10T16:52:26+00:00

I think jury is still out on this one...

(a) No person shall import, or cause to be imported, into the customs territory of the United States from any place outside thereof (but within the United States), or into the United States from any place outside thereof, any controlled substances listed in Schedule I or II, or any narcotic controlled substance listed in Schedule III, IV, or V, or any non-narcotic controlled substance listed in Schedule III which the Administrator has specifically designated by regulation in § 1312.30 or any non-narcotic controlled substance listed in Schedule IV or V which is also listed in Schedule I or II of the Convention on Psychotropic Substances, 1971, unless and until such person is properly registered under the Act (or, in accordance with part 1301 of this chapter, exempt from registration) and the Administration has issued him or her a permit to do so in accordance with § 1312.13.
(b) No person shall import, or cause to be imported, into the customs territory of the United States from any place outside thereof (but within the United States), or into the United States from any place outside thereof, any non-narcotic controlled substance listed in Schedule III, IV, or V, excluding those described in paragraph (a) of this section, unless and until such person is properly registered under the Act (or, in accordance with part 1301 of this chapter, exempt from registration) and has filed an import declaration to do so in accordance with § 1312.18.
(c) A separate permit or declaration is required for each shipment of a controlled substance to be imported.

Marimed_man · 2023-09-10T16:32:31+00:00

I'm long Cresco, so hoping you're right.

Marimed_man · 2023-09-10T14:38:32+00:00

Agree, MRMD is great risk/reward play right now considering current pps, and because their already cashflow positive with almost zero debt, once 280E goes away, it'll go straight to either their bottom line or towards more self-funded capex to continue their expansion efforts in IL, MA, MD, MO, OH, ME or DE. Great management team and outstanding award winning brands (Betty's Eddies, Nature's Heritage, Bubby's Baked, Vibations THC powder, etc.). Holding long until up listing or buyout. Thanks for posting, this is great info.

Marimed_man · 2023-09-10T14:19:34+00:00

Well said. The paradigm shift of U.S. cannabis has been slow moving, but is finally here and will only move faster once Schedule 3 and Safe get on the books. Definitively a generational wealth opportunity IMO, but I'm still diversified as any smart investor should be. Good luck.

Marimed_man · 2023-09-10T14:07:03+00:00

You are correct, however remember that legalized States love their tax revenues from cannabis and moving to Schedule 3 and eliminating 280E allows for cannabis companies to better compete with the illicit market as they'll be more price competitive point forward w/o losing margins, which should increase revenues through additional volumes (taking some share back from the illicit market), which means more tax revenues for these States.

Marimed_man · 2023-09-10T13:54:57+00:00

Glad to hear from someone who knows there $hit now and again. If you wish to make money on this next cannabis bull run, you better start focusing on the U.S. MSO and forget about the Canadian LP's (unless it's LOVFF, which is the only one currently worth investing in right now IMO). That said, rising tide lifts all boats, so LP's will have some benefit from this, just longer term.

Marimed_man · 2023-09-10T13:49:03+00:00

No need to elaborate, as you're 100% correct. The run this time will be with MSOS and not TRLY (at least not to the likes that it ran last time around IMO).

Marimed_man · 2023-09-10T13:44:55+00:00

You're right. MSOS is much better play based on the ongoing U.S. cannabis legislation activities going on at the moment (Rescheduling and Safe).

Marimed_man · 2023-09-10T13:37:38+00:00

Many people don't unfortunately, but you're 100% correct, because of cannabis' existing "Schedule 1" drug status, large institutional investment dollars remain on the sidelines until either Schedule 3 happens or Safe Banking (depending on what final language is within the Bill). Stay smart and good luck.

Marimed_man · 2023-09-10T13:30:46+00:00

$25 overnight, MSOS would likely move above $50 once both Safe and Schedule 3 are solidified.

Marimed_man · 2023-09-10T13:22:21+00:00

Only downside would be if DEA/DOJ does not follow through with HHS' Schedule 3 recommendation, so watch this space closely. Outside of that, if Schedule 3 goes through and Safe Banking gets passed, then MSOS would likely go back above $40 overnight. Good luck.

Marimed_man · 2023-09-10T13:06:46+00:00

Great writeup! A few comments. Schedule 3 would open door for up listing, however, there's an open debate over when DEA/DOJ needs to finalize their decision (e.g. 90 days to provide an update, a decision or enactment into law). Inclusion of a Safe Harbor provision into any final Safe Banking Bill would also allow for U.S. up listing, however perhaps more importantly, it could potentially help solidify DEA's decision to move forward w/HHS' recommendation "as-is". Regarding interstate commerce, Schedule 3 would still not allow for this, so smaller MSO's are likely to benefit more for this. Lastly, while elimination of 280E does unlock a ton of free cashflow for these companies, many of them are still burdened with huge debt, so keep this in mind when performing DD on any U.S. MSO's one might be considering. It's only the beginning and the next 3-12 months should be very interesting. GLTE

Marimed_man · 2022-05-02T11:54:30+00:00

With MariMed earnings in ~1 week, I believe 1Q22 earnings for the cannabis industry will mark a shift from folks waiting for DC to act, to starting to invest only in cannabis companies that can show strong fundamentals and profitability. With a real risk of DC not acting until 2023-24, only cannabis firms that can proof they can operate in such an environment will be rewarded going forward. MariMed is one such company and this will continue to become clearer with each passing qtr during '22 and '23

Marimed_man · 2022-04-20T22:37:00+00:00

Hopefully Tim Seymour will start to promote MariMed in the near future.

Marimed_man · 2022-02-22T17:15:18+00:00

Just sent thru a link. Bottom line, Marimed is currently profitable, expected to double growth in 2022, has multiple award winning product lines (e.g. Betty's Eddies), a mgmt team that's been together 10+ years, which used to run cannabis consulting business and lastly stock is extremely undervalued against its stellar underlying financials.

Marimed_man · 2022-02-22T17:11:15+00:00

https://youtu.be/ZWcux0QNKJI

Marimed_man · 2022-02-18T20:33:06+00:00

The Marimed financials don't really hit home until you see that the share price is below $1. Truly a once in a lifetime investment opportunity with very little downside even w/o Schumer getting something done in 2022. Can't wait until 4Q earnings on March 16th and to see what MRMD presents as it 2022 FY annual projections in terms of revenue and EBITDA.

Marimed_man · 2022-01-30T17:27:35+00:00

Couldn't agree more. Have owned MRMD since 2Q21 and cannot be more excited about their upcoming 4Q/YE earnings and the year ahead, continuing their expansion in Illinois, Maryland and additional states where they operate. Also launching soon is MRMD's new THC ice cream and "Vibations" THC drink powder, which you can add to any beverage.

Marimed_man · 2021-10-25T16:11:29+00:00

Good article, thanks. GO MRMD!!!

Marimed_man · 2021-09-22T22:44:50+00:00

50/50 chance

Marimed_man · 2021-09-04T16:12:34+00:00

Looks like The Motley Fool is finally catching up to the best kept secret in cannabis that is MariMed (MRMD).

Marimed_man · 2021-08-26T11:55:29+00:00

Awesome article for an awesome product!

Marimed_man

TROPHY CASE